July 22, 2014
Unique Pharmaceuticals has issued a voluntary recall of sterile compounded preparations, but aired concerns about FDA?s recall demand.
|
July 21, 2014
By:
Melanie Sena
AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.
|
July 18, 2014
By:
Melanie Sena
AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.
|
July 18, 2014
After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.
|
July 17, 2014
Baxter investigates root cause of cellulosic fibers and/or plastics in four lots of IV solutions.
|
July 14, 2014
Mylan set to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction.
|
July 14, 2014
New AbbVie proposal results in discussion with Shire about possible $53 billion deal.
|
July 11, 2014
Puncture in container and overwrap cause leak in intravenous solution, leading to recall by Hospira.
|
July 11, 2014
Baxter Healthcare has initiated a nationwide recall of more than 20,000 containers of a pre-mixed beta blocker due to the presence of particulate matter.
|
|
